Deepika Pakianathan is of Theravance Biopharma, Inc.. Currently has a direct ownership of 58,065 shares of TBPH, which is worth approximately $659,037. The most recent transaction as insider was on May 19, 2025, when has been sold 10,649 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 58.1K
22.46% 3M change
22.46% 12M change
Total Value Held $659,037

DEEPIKA PAKIANATHAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 19 2025
BUY
Grant, award, or other acquisition
-
10,649 Added 15.5%
58,065 Ordinary Shares
May 08 2024
BUY
Grant, award, or other acquisition
-
10,537 Added 18.18%
47,416 Ordinary Shares
May 02 2023
BUY
Grant, award, or other acquisition
-
9,132 Added 19.85%
36,879 Ordinary Shares
Apr 26 2022
BUY
Grant, award, or other acquisition
-
9,852 Added 26.2%
27,747 Ordinary Shares
Apr 27 2021
BUY
Grant, award, or other acquisition
-
9,828 Added 35.45%
17,895 Ordinary Shares

Also insider at

KPTI
Karyopharm Therapeutics Inc. Healthcare
CALA
Calithera Biosciences, Inc. Healthcare
PRDS
PARDES BIOSCIENCES, INC. Healthcare
MREO
Mereo Biopharma Group plc Healthcare
DP

Deepika Pakianathan

South San Francisco, CA

Track Institutional and Insider Activities on TBPH

Follow Theravance Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TBPH shares.

Notify only if

Insider Trading

Get notified when an Theravance Biopharma, Inc. insider buys or sells TBPH shares.

Notify only if

News

Receive news related to Theravance Biopharma, Inc.

Track Activities on TBPH